ClinicalTrials.Veeva

Menu

Evaluation of the Efficacy of a New Formula in Infants With Cow's Milk Protein Allergy (Paradice)

U

United Pharmaceuticals

Status

Completed

Conditions

Milk Hypersensitivity
Protein Allergy
Food Sensitivity

Treatments

Dietary Supplement: extensively hydrolyzed rice protein formula

Study type

Interventional

Funder types

Industry

Identifiers

NCT01998074
UP2010-Paradice
BUN 143201010095 (Other Identifier)

Details and patient eligibility

About

The aim of the study is to show the efficacy, tolerance and nutritional adequacy of a newly developed hydrolyzed rice formula in infants with a proven cow's milk protein allergy.

Sex

All

Ages

2 weeks to 6 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Infants between 2 weeks and 6 months old
  • In whom cow's Milk Protein Allergy has been proved by a food challenge performed during the previous month

Exclusion criteria

  • Exclusively breast fed infants
  • Preterm infants
  • Infants already fed with an extensively hydrolyzed formula with no improvement of the symptoms.
  • Infants fed an amino acid based formula
  • Infants who had an anaphylactic reaction in the past

Trial design

0 participants in 1 patient group

Study formula
Experimental group
Treatment:
Dietary Supplement: extensively hydrolyzed rice protein formula

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems